Fifth Third Wealth Advisors LLC Has $4.10 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fifth Third Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 94.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,338 shares of the medical equipment provider’s stock after purchasing an additional 4,050 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $4,096,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Lake Street Advisors Group LLC grew its position in shares of Intuitive Surgical by 96.2% in the first quarter. Lake Street Advisors Group LLC now owns 2,833 shares of the medical equipment provider’s stock valued at $1,131,000 after purchasing an additional 1,389 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in Intuitive Surgical by 10,606.9% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 12,420 shares of the medical equipment provider’s stock worth $4,957,000 after buying an additional 12,304 shares during the period. Natixis boosted its position in shares of Intuitive Surgical by 9.4% in the first quarter. Natixis now owns 49,706 shares of the medical equipment provider’s stock valued at $19,837,000 after acquiring an additional 4,266 shares during the period. Crewe Advisors LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at about $161,000. Finally, Northwest Wealth Management LLC bought a new position in Intuitive Surgical during the first quarter worth about $216,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $531.64 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $544.38. The stock has a 50 day moving average price of $500.33 and a two-hundred day moving average price of $459.58. The firm has a market capitalization of $189.36 billion, a P/E ratio of 85.47, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. BTIG Research set a $535.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Truist Financial increased their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.